AMRS Stock Forecast: What Will Amyris Stock Do?

Will AMRS stock rise or fall? Let’s look at some of the main elements of Amyris (Nasdaq:AMRS). So, we can decide together if it’s a good investment or not. In 2020, the stock increased ten-fold at least. And since then, it’s come back down to a much more manageable price. Plus, it’s a price that’s cheap and still down from it’s high.

So, this presents a great opportunity for investors.

Many of the items we use are harmful to the environment in one way or another. AMRS stock is a company that uses sustainable ingredients. And the company uses them to create better alternatives for everyday items. They’re doing this with synthetic biology, mimicking naturally found ingredients.

Because harvesting many of these ingredients can cause a lot of havoc very quickly. Case in point, there is an ingredient called squalene. And it’s needed for COVID-19 vaccines. This is naturally found in shark livers. Now, I don’t know what the process is for acquiring squalene. But, there are plenty of similar stories that’re doing damage to environments.

Also, creating many of these ingredients can cause a lot of harm fast. Case in point, all the plastic we go through every day, month and year. Pollution and trash everywhere kill animals. And this travels through the food chain. Many times, grazing animals mistake it for food and try to eat it. And so far, it’s been a struggle to create an alternative that works well. Or, something that works better.

Recycling helps a bit. But it doesn’t seem to work. Much of it ends up in the trash anyways. Even if it has been recycled once or twice. And plastic alternatives seem to be flimsy or break down too fast. So, it’s obvious we need to figure something else out.

AMRS stock is stepping up and working hard to figure out better alternatives. These ingredients and products are for the beauty and health industries. Now, sometimes when we try to replicate natural materials, it does more harm than good. So, it’s important for Amyris to have strategies in place that keep them from losing sight of the real goal here. To strengthen and do what’s best for all ecosystems collectively.

One awesome fact about AMRS stock, it started with a grant from the Bill and Melinda Gates Foundation. And they were finding a treatment for malaria. AMRS currently has 13 ingredients that are used by global brands. And not just a few. They’re used by over 3,000 top global brands and put into their products.

So, I’d say the leadership is doing well. AMRS operates all around North and South America, Europe and Asia-Pacific. The management of Amyris has varied experience in many different industries. This is often a good sign because each person brings something different to the table. And, these people bring decades of experience to each role.

On top of this, the Board of Directors is a long one. Plus, it is also varied, and its members are quite successful. One of those members is John Doerr. And he’s previously been on the Board of Directors for many successful companies. Including Amazon.com.

AMRS stock has a rich history. Because in 2004, it began with a bang. With a grant from Bill and Melinda Gates, the company produced a molecule to treat malaria. In 2010, it announced its IPO. In 2011, AMRS produced another molecule. And partnered up to produce three flavor and fragrance ingredients. Since then, they’ve been growing and scaling.

Recently, the company has been very busy. Reese Witherspoon has joined one of its brands as an ambassador. They’ve started building a manufacturing plant in Brazil. And even purchased several beauty brands. In 2019, AMRS launched a brand called Pipette. And in 2020, it scaled and distributed hand sanitizer using this platform. In 2021, the company made deals for distribution of its unique ingredients.

Also in 2019, they also launched a brand called Purecane. It’s zero-calorie baking sweetener. And in 2020, they earned the Bonscuro Certified Sustainable Sugarcane certification.

So, it’s obvious AMRS has been doing a lot with its years of existence. This is great news for investors and those who are interested in doing business with AMRS stock.

AMRS stock does business in the health and clean beauty markets. As the human population turns to more earth-friendly alternatives? That spells out great news for companies like Amyris. Health and beauty are great industries for such ‘clean product’ companies.

Because its customers are already in a state where they’re willing to pay a little more to do some good. Health and beauty are both ‘feel good’ industries. And it does feel good to help a great cause.

AMRS does a great job of using technology to create these ingredients. And, people are very trusting in technology. As it becomes more advanced and effective, we trust it more. Plus, the health and beauty industries are two that won’t be fading for quite some time, if ever. Or at least until the human population is around.

Revenues for AMRS stock are up, which is great. And that means they can grow the business naturally, but quickly.

AMRS stock has a market cap of around $1.4 billion. So, it has become a unicorn. But, if you’re worried you’ve missed out, you haven’t. Just because a business has reached unicorn status doesn’t mean it’s finished growing. In fact, companies that’ve reached $1 billion are still considered small! And anything from $2 billion to $10 billion are medium market caps. So, you have plenty of room to get in.

AMRS stock seems to be a solid company. They are in a combination of great industries that are set to grow for a while. The leadership and history are strong. And it has a sizable market cap. So, it’s obvious AMRS is a thriving company. Plus, it’s recently crossed that unicorn status. Which is a big deal.

AMRS doesn’t offer a dividend. So, if you were hoping for that, you’ll be disappointed. Plus, it should be kept in mind that it’s important they don’t get off track. And by that, I mean that they don’t lose sight of the focus. That focus is creating alternatives that do more good than harm.

Sometimes, creating alternatives can be worse than the original product. I’m not saying that’s happening with AMRS stock. I’m saying it’s something to keep in mind. Even for other companies in similar industries. Aside from those two things, Amyris seems to be a great investment.